About
Cathy Friedman is a business executive with nearly 40 years of experience across finance, technology, and healthcare. Cathy is an Executive Venture Partner at GV, where she is a senior member of the investing team and advises the life sciences portfolio. Cathy has spent 15 years on the boards of leading public and private life sciences and technology companies. Recently, in addition to her role as Chair of the Board at Grail (acquired by Illumina), she has been an independent director at Vividion Therapeutics (acquired by Bayer), Lyell Immunopharma, Seer, Altaba (formerly Yahoo!), Radius Health, and Revolution Healthcare Acquisition Corp. Earlier in her career, Cathy spent nearly 24 years with Morgan Stanley. She held several executive positions, including Managing Director, Head of West Coast Healthcare, and co-head of Morgan Stanley's biotechnology practice. Cathy holds a B.A. in economics from Harvard University and an M.B.A from The University of Virginia's Darden School of Busines…
Experience
Board Member
Lyell Immunopharma · South San Francisco, California
Present
Board Member
Altaba.com · New York, New York
Board Member
Board Member
Revolution Health Acquisition Corp · United States
Chairperson
GRAIL, Inc. · Menlo Park, California
Board Member
Radius Health, Inc. · Waltham, Massachusetts
Managing Director
Morgan Stanley · New York, London, San Francisco, Silicon Valley
Held numerous executive positions during a 23-year investment banking career with Morgan Stanley, including Managing Director (1997-2006), and Head of West Coast Healthcare and Co-Head of the Biotechnology Practice (1993-2006).
Education
University of Virginia Darden School of Business
Master of Business Administration - MBA
Harvard University
AB, Economics
Find leads like Cathy
Origami finds your ideal customers across 15+ data sources with a single prompt.
Try Origami Free